ALLO vs PG · rev $22.0K vs P/E 25, rev $84.28B
Allogene Therapeutics Inc (ALLO) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ALLO currently screens at market cap $258.1M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ALLO and PG stock pages for the full models.
Not investment advice.